Results 41 to 50 of about 1,097,093 (360)

A case of successful late steroid withdrawal after ABO-incompatible kidney transplantation

open access: yesKorean Journal of Transplantation, 2020
Few data exist regarding steroid withdrawal in ABO-incompatible (ABO-i) kidney transplantation (KT). Here, we report a case of steroid withdrawal after ABO-i KT. A 46-year-old man diagnosed with Henoch-Schonlein purpura received ABO-i KT from his 42-year-
Jeong Min Cho   +5 more
doaj   +1 more source

Neonatal Hyperbilirubinemia associated with Minor Blood Group Incompatibility: Two Case Reports

open access: yes, 2017
1. Associate Professor, Department of Neonatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka. 2. Specialist, Department of Neonatology, United Hospital Ltd. Gulshan, Dhaka. 3.
S. Dey   +4 more
semanticscholar   +1 more source

Wolbachia and arbovirus inhibition in mosquitoes [PDF]

open access: yes, 2013
Wolbachia is a maternally inherited intracellular bacteria that can manipulate the reproduction of their insect hosts, and cytoplasmic incompatibility allows them to spread through mosquito populations.
Sinkins, Steven P.
core   +1 more source

Severe Neonatal Hyperbilirubinemia; Causes and Contributing Factors Leading to Exchange Transfusion at Ghaem Hospital in Mashhad [PDF]

open access: yesActa Medica Iranica, 2010
"nHyperbilirubinemia is common in neonates; it can have a serious rising course. Due to its critical morbidity called "kernicterus", severe neonatal hyperbilirubinemia causes which lead to exchange transfusion, should be clarified.
Farhad Heydarian, Mina Majdi
doaj   +2 more sources

Current progress in ABO-incompatible kidney transplantation

open access: yesKidney Research and Clinical Practice, 2015
ABO-incompatible kidney transplantation (ABOi KT) was introduced to expand the donor pool and minimize shortage of kidneys for transplantation. Because improved outcomes of ABOi KT were reported in Japan in the early 2000s, the number of ABOi KTs has ...
Tai Yeon Koo, Jaeseok Yang
doaj   +1 more source

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies. [PDF]

open access: yes, 2015
Treatment of hematological malignant disorders has been improved over the last years, but high relapse rate mainly attributable to the presence of minimal residual disease still persists.
Biassoni   +67 more
core   +1 more source

Blood group discrepancy in mixed-type autoimmune hemolytic anemia in a pediatric patient

open access: yesAsian Journal of Transfusion Science, 2021
Autoimmune hemolytic anemia (AIHA) is characterized by the presence of antibodies directed against self-antigens on red blood cells (RBCs) leading to progressive RBC destruction along with reduced red cell survival.
Minal Wasnik   +3 more
doaj   +1 more source

Desensitization for ABO incompatible kidney transplantation: Experience of a single center in Brazil. ABO incompatible kidney transplantation

open access: yesTransplantation Reports, 2017
Introduction: About 25% of the living donors analyzed for kidney donation are ABO incompatible, but ABO incompatibility can be successfully overcome by using various desensitization protocols.
Maria Cristina Ribeiro Castro   +7 more
doaj   +1 more source

Resistance to carbapenems in non-typhoidal Salmonella enterica serovars from humans, animals and food [PDF]

open access: yes, 2018
Non-typhoidal serovars of Salmonella enterica (NTS) are a leading cause of food-borne disease in animals and humans worldwide. Like other zoonotic bacteria, NTS have the potential to act as reservoirs and vehicles for the transmission of antimicrobial ...
Fernández, J.   +2 more
core   +3 more sources

Changes of circulating anti-A/B-antibody titers during the preparation period and after AB0-incompatible living donor kidney transplantation

open access: yesТрансплантология (Москва), 2018
Several protocols have been developed to overcome the blood group barrier in renal transplantation. In the evolution of these protocols, one of the latest steps was the combination of anti-CD20 treatment with antigen-specific immunoadsorption (IA) and ...
A. I. Sushkov, Ya. G. Moisyuk
doaj   +1 more source

Home - About - Disclaimer - Privacy